The effect of plasma human immunodeficiency virus RNA and CD4+ T lymphocytes on growth measurements of hemophilic boys and adolescents

被引:7
作者
Hilgartner, MW
Donfield, SM
Lynn, HS
Hoots, WK
Gomperts, ED
Daar, ES
Chernoff, D
Pearson, SK
机构
[1] New York Presbyterian Hosp, Cornell Med Ctr, Dept Pediat Hematol & Oncol, New York, NY 10021 USA
[2] Rho Inc, Chapel Hill, NC USA
[3] Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77225 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77225 USA
[5] Childrens Hosp Los Angeles, Dept Hematol Oncol, Los Angeles, CA 90027 USA
[6] Cedars Sinai Burns & Allen Res Inst, Dept Med, Div Infect Dis, Los Angeles, CA USA
[7] Chiron Corp, Emeryville, CA 94608 USA
关键词
hemophilia; physical growth; human immunodeficiency virus; immune function; RNA;
D O I
10.1542/peds.107.4.e56
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. The investigation examined the associations of plasma human immunodeficiency virus (HIV) RNA and CD4(+) T lymphocytes with height, weight, skeletal maturation, testosterone levels, and height velocity for hemophilic children and adolescents with HIV infection in the Hemophilia Growth and Development Study. Study Design. Two hundred seven participants were evaluated over 7 years. Results. A threefold increment in baseline plasma HIV RNA was associated with a 0.98-cm decrease in height and a 1.67-kg decrease in weight; 100-cells/muL decrements in baseline CD4(+) were associated with a 2.51-cm decrease in height and a 3.83-kg decrease in weight. Participants with high plasma HIV RNA (> 3125 copies/mL) experienced significant delay in achieving maximum height velocity and lower maximum velocity compared with those with low viral load. The high CD4(+) (> 243)/low plasma HIV RNA group had earlier age at maximum height velocity compared with the other 3 groups and higher maximum height velocity compared with the low CD4(+)/high plasma HIV RNA and low CD4(+)/low plasma HIV RNA groups. Decrements in CD4(+) were associated with decreases in bone age and testosterone level. Conclusions. CD4(+) and HIV RNA were important in predicting growth outcomes.
引用
收藏
页数:5
相关论文
共 27 条
[1]   The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements [J].
Brambilla, D ;
Reichelderfer, PS ;
Bremer, JW ;
Shapiro, DE ;
Hershow, RC ;
Katzenstein, DA ;
Hammer, SM ;
Jackson, B ;
Collier, AC ;
Sperling, RS ;
Fowler, MG ;
Coombs, RW .
AIDS, 1999, 13 (16) :2269-2279
[2]   GROWTH FAILURE AS A PROGNOSTIC INDICATOR FOR PROGRESSION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN CHILDREN WITH HEMOPHILIA [J].
BRETTLER, DB ;
FORSBERG, A ;
BOLIVAR, E ;
BREWSTER, F ;
SULLIVAN, J .
JOURNAL OF PEDIATRICS, 1990, 117 (04) :584-588
[3]  
Carroll RJ., 1995, MEASUREMENT ERROR NO
[4]   Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs [J].
Daar, ES ;
Lynn, H ;
Donfield, S ;
Gomperts, E ;
Hilgartner, MW ;
Hoots, K ;
Chernoff, D ;
Winkler, C ;
O'Brien, SJ .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (04) :317-325
[5]  
DAVIDIAN M, 1997, NONLINEAR MODELS REP
[6]   APPLICATION OF BRANCHED DNA SIGNAL AMPLIFICATION TO MONITOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BURDEN IN HUMAN PLASMA [J].
DEWAR, RL ;
HIGHBARGER, HC ;
SARMIENTO, MD ;
TODD, JA ;
VASUDEVACHARI, MB ;
DAVEY, RT ;
KOVACS, JA ;
SALZMAN, NP ;
LANE, HC ;
URDEA, MS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1172-1179
[7]  
Diggle P. J., 2002, ANAL LONGITUDINAL DA
[8]   DELAYED SOMATIC GROWTH AND PUBERTAL DEVELOPMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HEMOPHILIAC BOYS - HEMOPHILIA GROWTH AND DEVELOPMENT STUDY [J].
GERTNER, JM ;
KAUFMAN, FR ;
DONFIELD, SM ;
SLEEPER, LA ;
SHAPIRO, AD ;
HOWARD, C ;
GOMPERTS, ED ;
HILGARTNER, MW .
JOURNAL OF PEDIATRICS, 1994, 124 (06) :896-902
[9]   Resting energy expenditure and body composition in children with HIV infection [J].
Henderson, RA ;
Talusan, K ;
Hutton, N ;
Yolken, RH ;
Caballero, B .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (02) :150-157
[10]  
HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208